Skip to main content
Caplight Logo









Redux Bio

Redux Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.reduxbio.com/

Last Round

Seed

Nov 12, 2021

Total Funding Raised

$3M

Company Overview

Redux Bio is an aquaculture company that develops preventative disease management tools as sustainable alternatives to antibiotics for livestock and aquaculture farmers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

animal healthRNAi biotechnologyaquaculture healthRNAi therapeuticsantibiotic alternativesagritechaquatechshrimp farmingRNA interferenceantiviral medicineWhite Spot Syndrome VirusWSSVlivestock healthorally-delivered medicinepreventative animal healthengineered microalgae

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Redux Bio Comparables

Compare Redux Bio with similar companies based on industry and business-model similarity.

Redux Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ViAqua Therapeutics
87%
AquaNab Solutions
76%
Boehringer Ingelheim
61%

Redux Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 12, 2021

Key People

Founding team and executive leadership

Lincoln Tubbs

Chief Executive Officer

Executive Team

Redux Bio Investors

Notable investors and investment history

Redux Bio investors
InvestorRounds
Genoa VenturesSeed

Redux Bio Filings

Explore SEC and related filing metadata, where available.

Redux Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Redux Bio's valuation, stock price, and market status.

Is Redux Bio a public or private company?

Redux Bio is a private company.

What is the current stock price of Redux Bio?

Redux Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Redux Bio worth (valuation)?

Valuation information for Redux Bio is not publicly available.

Can I buy Redux Bio stock?

Redux Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Redux Bio's last funding round?

Funding round information for Redux Bio is not publicly available.

Who are the main investors in Redux Bio?

Investor information for Redux Bio is not publicly disclosed.

Will Redux Bio IPO soon?

No public IPO plans have been announced for Redux Bio.

How can I track Redux Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Redux Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range6
Year Founded2021
Last FundingNov 12, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?